215
Views
28
CrossRef citations to date
0
Altmetric
Original

Overexpression of Reg3α increases cell growth and the levels of cyclin D1 and CDK4 in insulinoma cells

, , , , , & show all
Pages 195-202 | Received 15 Sep 2008, Accepted 27 Feb 2009, Published online: 11 Jul 2009
 

Abstract

Regenerating gene (Reg) family protein Reg3α is normally expressed in pancreatic acinar and endocrine cells. In order to explore its effect on islet β-cell replication, insulinoma MIN6 cells were stably transfected with murine Reg3α cDNA. Determined using real-time PCR and Western blots, the levels of Reg3α mRNA and protein in Reg3α-transfected clones were increased 10- and 6-fold, respectively. Western blots also revealed that the protein was released into the culture medium, consistent with an endocrine effect. In MTT cell proliferation assay, Reg3α-overexpressing cells exhibited a 2-fold increase in the rate of cell growth. In order to investigate the intracellular mechanism, we studied cell cycle regulatory proteins. In Reg3α-expressing cells, we detected 2.2- and 2.5-fold increased levels of cyclin D1 and CDK4, respectively, which paralleled a 1.8-fold increase in the rate of Akt phosphorylation. It is established that β-cell replication is associated with increased cyclin D1 and CDK4 levels; deficiency in CDK4 or cyclin D2 results in reduced β-cell mass and diabetes. Our results suggest that Reg3α stimulates β-cell replication, by activating Akt kinase and increasing the levels of cyclin D1/CDK4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.